Galmed Pharmaceuticals (NASDAQ:GLMD) Earns Sell Rating from Analysts at StockNews.com
Equities researchers at StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a report released on Tuesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of GLMD opened at $1.94 on Tuesday. Galmed Pharmaceuticals has a 1 year low of $1.90 and […]
Equities researchers at StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a report released on Tuesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of GLMD opened at $1.94 on Tuesday. Galmed Pharmaceuticals has a 1 year low of $1.90 and […]
